YSM Issue 96.4
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Medicine<br />
FOCUS<br />
Alcoholism<br />
has a substantial<br />
impact on both mental and<br />
physical health and can present different<br />
features among affected individuals. Due to<br />
this, the mechanisms and possible causes of<br />
alcoholism cannot be as easily identified as<br />
diseases such as hemophilia, which presents<br />
clear physical symptoms. But in the decades<br />
since Angier’s article, scientists have made<br />
strides in figuring out the mystery of what<br />
really underlies this unique disease.<br />
Searching for AUD in Our Genes<br />
In 1990, an initially promising study of the<br />
genetic basis of alcoholism was conducted by<br />
Kenneth Blum, a professor at the University<br />
of Texas Health Science Center. The study<br />
found that there was a very strong connection<br />
between the D2 dopamine receptor gene and<br />
the development of alcoholism or problematic<br />
drinking behaviors. In their patient sample,<br />
the researchers found that in those with AUD,<br />
all had a higher frequency of one specific allele<br />
in the dopamine D2 receptor gene, suggesting<br />
that it was strongly associated with AUD.<br />
However, one year later, Joel Gelernter, a<br />
professor of genetics and neuroscience at the<br />
Yale School of Medicine, along with his team<br />
could not find the association between the D2<br />
dopamine receptor gene and AUD, showing a<br />
lack of replicability in the earlier study.<br />
While the D2 dopamine receptor gene did<br />
not have the effect expected on alcoholism,<br />
the study contributed to moving forward<br />
genetic research. “We know now that it was<br />
only a first step of a very long road of complex<br />
genetics,” said Renato Polimanti, a colleague<br />
of Gelernter at the Yale School of Medicine.<br />
In contrast to Angier’s conclusion that AUD<br />
is decided by the environment, scientists have<br />
since found multiple genetic players.<br />
The effort to uncover the genetic mysteries of<br />
AUD was—and is—long from over. Between<br />
the D2 dopamine receptor findings in the<br />
1990s and 2020, researchers have identified<br />
more than a dozen variants for AUD. In 2020, a<br />
research team including Gelernter, Polimanti,<br />
and Hang Zhou, an assistant professor of<br />
psychiatry at Yale, was able to greatly expand<br />
upon previous findings regarding alcoholism<br />
through a genome-wide association study<br />
published in Nature Neuroscience.<br />
www.yalescientific.org<br />
The team was able to identify twenty-nine<br />
genes linked to increased risk of problematic<br />
alcohol use—nineteen of them novel—in the<br />
human genome, extending the known genetic<br />
architecture of the disorder and giving other<br />
scientists a wider breadth of targets for followup<br />
studies. Researchers found that six to<br />
eleven percent of the phenotypic variation—<br />
referring to differences in what physical and<br />
behavioral traits are expressed—could be<br />
explained by genetic information.<br />
The goal of genetic studies, however, is<br />
not only to find associations but also to<br />
understand how these variants might promote<br />
the development of AUD. In their study,<br />
the Yale team discovered that the risk genes<br />
were correlated to changes in certain brain<br />
regions. This finding suggested to researchers<br />
that the risk variants promoted certain brain<br />
pathways that contribute to the development<br />
of behavior patterns and disorders.<br />
Such pathways are not exclusive to AUD.<br />
The researchers discovered a strong genetic<br />
correlation between problematic alcohol<br />
use and 138 other conditions, including<br />
substance abuse disorders, depression, and<br />
schizophrenia. “AUD has many variants<br />
across the genome that are involved in the<br />
predisposition of this trait, but these variants<br />
are not only predisposing to AUD, they are<br />
predisposing to many things,” Polimanti<br />
said. “It can depend on where [risk variants]<br />
play a role, maybe in sensitivity to a<br />
substance, or to addiction pathways in the<br />
brain, or to reward systems.”<br />
Moving Forward<br />
This research does not mean AUD is solely<br />
explained by genetics. Rather, in AUD, only<br />
about fifty percent of the risk appears to be<br />
attributed to our genes. This is relatively<br />
ABOUT THE<br />
AUTHORS<br />
small in comparison to schizophrenia,<br />
where genetics can explain eighty percent<br />
of the disease predisposition. Therefore, as<br />
research progresses, consideration must<br />
still be made for the environment—the<br />
“nurture”—that individuals were raised and<br />
live in. “Genetic variants among individuals<br />
cannot explain everything. We need to<br />
spend more time in gene discovery before<br />
bringing it into patient care,” Zhou said.<br />
Beyond addressing the nature versus<br />
nurture debate, this research has a broader<br />
aim. According to Polimanti and Zhou,<br />
geneticists hope to be able to bring their<br />
findings to human healthcare in order to<br />
help predict and treat certain illnesses. This is<br />
called precision medicine, wherein a person’s<br />
treatment plan can be specially tailored based<br />
on their unique genetic makeup.<br />
Until we get there, research will continue<br />
focusing on identifying genetic variants and<br />
possible mechanisms behind risk. Polimanti<br />
explained that for certain illnesses like<br />
cardiovascular disease, the field of genetics<br />
is expected to transform treatments in the<br />
coming years. “We will keep doing gene<br />
discovery and use increasingly advanced<br />
technology to deliver this information and get<br />
a deeper understanding of the role genetics<br />
play in human health,” Zhou said.<br />
The study of AUD has been marked<br />
by both successes and failures. Now, we<br />
enter an exciting time where genetic and<br />
environmental studies promise great strides<br />
for the understanding of our human genome<br />
and real changes in clinical care. Nature and<br />
nurture, instinctivists and environmentalists,<br />
the D2 dopamine receptor and twenty-nine<br />
other discovered genes, and, now, precision<br />
medicine, are all important themes in the<br />
long and evolving story of alcoholism and<br />
scientific discovery. ■<br />
MATTHEW BLAIR<br />
LEA PAPA<br />
MATTHEW BLAIR is a sophomore in Benjamin Franklin College from Manchester, NH, majoring in<br />
the History of Science, Medicine, and Public Health. In addition to copy editing for <strong>YSM</strong>, Matthew<br />
conducts lung cancer research in the Schalper Lab at the Yale School of Medicine and plays for the<br />
club ice hockey team.<br />
LEA PAPA is a sophomore in Ezra Stiles College from South Milwaukee, WI, studying neuroscience.<br />
Outside of <strong>YSM</strong>, Lea is involved in Yale’s Questbridge Chapter, is working towards becoming an EMT,<br />
and recently joined the Yale Undergraduate Research Journal Humanities Committee.<br />
THE AUTHORS WOULD LIKE TO THANK Renato Polimanti and Hang Zhou for their time and expertise.<br />
December 2023 Yale Scientific Magazine 15